Crossmark

Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

Crossref DOI link: https://doi.org/10.1186/s43088-023-00446-w

Published Online: 2024-01-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ugorji, Onyinyechi Lydia

Onyishi, Ikechukwu Virgilius

Onwodi, Julie Ngozichukwuka

Adeyeye, Christiania Moji

Ukachukwu, Uzochukwu Gospel

Obitte, Nicholas Chinedu
License Information

Text and Data Mining valid from 2024-01-04

Version of Record valid from 2024-01-04
More Information

Article History

Received: 29 January 2023

Accepted: 14 November 2023

First Online: 4 January 2024

Declarations

:

: The Animal Ethics Committee of the Faculty of Pharmaceutical Science, University of Nigeria, Nsukka approved the research protocol for the use of experimental animals. Hence, the study was conducted in accordance with the Ethical Guidelines of the Animal Care and Use Committee (Research Ethics Committee) of the University of Nigeria, Nsukka following the Federation of European Laboratory Animal Science Association and the European Community Council Directive (86/609/EEC).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below